葛根素注射液眼部电离子导入治疗视频终端视疲劳临床观察

Observation on Clinical Effect of Eye Iontophoresis with Puerarin Injection in Treatment of Visual Display Terminal Asthenopia

目的:观察葛根素注射液眼部电离子导入治疗视频终端视疲劳的临床疗效,并初步探索其作用机理。方法:视频终端视疲劳患者90例,按就诊顺序1:1随机分为试验组和对照组。试验组给予葛根素注射液眼部电离子导入,对照组给予0.9%氯化钠注射液眼部电离子导入。疗程10天。观察治疗前后眼部及全身症状、坚持近距离用眼时间等疗效指标。结果:试验组总有效率为85%,对照组总有效率为47.5%,显效率及有效率与对照组比较均具有显著统计学意义(均P<0.01),试验组优于对照组。结论:葛根素注射液眼部电离子导入可延长VDT视疲劳患者近距离用眼时间,明显改善中西医症状。

Objective：To observe the clinical effect of eye iontophoresis with Puerarin Injection in treatment of visual display terminal （VDT） asthenopia, and to explore the mechanism of it initially. Methods ：90 patients with VDT asthenopia disease were divided into 2 groups as 1：1 proportion randomly. The test group was treated with eye iontophoresis with Puerarin Injection, and the control group was treated with eye iontophoresis with Sodium Chloride Injection. Patients were treated 10 days in each group. Symptoms of western medicine and TCM, the time of close visual work were observed before and after treatment. Results ： The total effective rate of the test group was 85% , and 47.5% for the control group after treatment. The differences had statistical significance in the effective rate and excellent rate between two groups （all P 〈 0. 01 ）, the effect of test group was better than control group. Cortclusion： Eye iontophoresis with Puerarin Injection can significantly improve the symptoms, and increase the time of close visual work in treating of VDT asthenopia.